DiaMedica Therapeutics Announces 2020 Financial Results and Provides a Business Update
Productive Type B Pre-IND Meeting with FDA Provides Clarity for Planned Stroke Study ProgramOn Track to Initiate Phase 2/3 AIS...
Productive Type B Pre-IND Meeting with FDA Provides Clarity for Planned Stroke Study ProgramOn Track to Initiate Phase 2/3 AIS...
